Dr Oluwatosin Babalola of WARIF connects sexual violence prevention with cervical cancer care, discussing policy gaps and the ...

Precigen Inc. (NASDAQ:PGEN) is one of the hot stocks to buy with huge upside potential. On October 13, Precigen announced ...

SINGAPORE, Oct. 18, 2025 /PRNewswire/ -- (SCG), a clinical-stage biotechnology company developing next-generation immunotherapies for infectious diseases and their associated cancers, announced the pr ...

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

Human papillomavirus vaccination reached 82.1% by 2023, lowering rates among both unvaccinated and vaccinated individuals.

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

Ficerafusp alfa is currently being evaluated in FORTIFI-HN01, a pivotal Phase 2/3 clinical trial in patients with first line (1L) recurrent/metastatic (R/M) head and neck squamous cell carcinoma ...

Pap smears are screening tools to detect any abnormal changes in cervical cells which may indicate cancer or HPV.

Three million people receive abnormal Pap smear results each year, but less than one percent are diagnosed with cervical cancer.

Could dental offices be a new front in the effort to vaccinate children against human papillomavirus (HPV)? The results of a new pilot project suggest the answer is yes, and the organizers of the ...